Publications » 2015

Show per page  
Conferences
31Vavers E.; Zvejniece L.; Dambrova M. Ligands of sigma-1 receptor: agonists, antagonists, allosteric modulators. P.63 (OP43).. Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

32Zvejniece L.; Vavers E.; Veinberg G.; Švalbe B.; Domracheva Ilona; Vilšķērsts R.; Dambrova M. Stereoselective pharmacological activity of 4,5-disubstituted piracetam derivatives, positive allosteric modulators of sigma-1 receptor. P.62 (OP42).. Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

33Kuka J.; Makrecka - Kuka M.; Cīrule H.; Grinberga S.; Dambrova M.; Liepins E. The comparative anti-infarction activity of selective L-carnitine transport and biosynthesis inhibitors. P.54 (OP34).. Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

34Makrecka - Kuka M.; Voļska K.; Kuka J.; Dambrova M.; Liepins E. Acylcarnitines in mitochondrial bioenergetics. P.46 (OP26).. Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

35Vilšķērsts R.; Kuka J.; Makrecka - Kuka M.; Volska K.; Makarova E.; Liepins E.; Dambrova M. Attenuation of atherosclerosis development by targeting acylcarnitine pools. P.37 (OP17).. Abstract Book, Drug Discovery conference, Drug Discovery conference ; Riga, Latvia: Riga, Latvia, 2015.      

36Makarova E.; Cīrule H.; Švalbe B.; Volska K.; Vilšķērsts R.; Kuka J.; Liepins E.; Dambrova M. Experimental models for novel anti-diabetic and anti-obesity drug testing. P120. Abstract Book, Drug Discovery conference , Drug Discovery conference ; Riga, Latvia: Riga, Latvia, 2015.      

37Volska K.; Makrecka - Kuka M.; Makarova N.; Svalbe B.; Sevostjanovs E.; Liepins E.; Dambrova M. Decreased acylcarnitine content and increased physical activity improve insulin sensitivity in db/db mice. P160. Abstract Book, Drug Discovery conference, , Drug Discovery conference, ; Riga, Latvia: Riga, Latvia, 2015.      

38Vilšķērsts R.; Kuka J.; Liepins E.; Dambrova M. Experimental models for the development of new cardiovascular drugs. P158.. Abstract Book, Drug Discovery conference, , Drug Discovery conference, ; Riga, Latvia: Riga, Latvia, 2015.      

39Liepins E. Long chain acylcarnitines: new target for treatment of cardiovascular diseases and type 2 diabetes. Drug Discovery conference, P.36 (OP16).. Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

40Antone U.; Makrecka - Kuka M.; Sevostjanovs E.; Dambrova M.; Liepins E. Plasma and tissue acylcarnitine profile in fed and fasting rats. P.86.. in Abstract Book, Drug Discovery conference, Drug Discovery conference; Riga, Latvia: Riga, Latvia, 2015.      

Show per page